594 related articles for article (PubMed ID: 19370564)
1. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Brown J; O' Brien PM; Marjoribanks J; Wyatt K
Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Wyatt KM; Dimmock PW; O'Brien PM
Cochrane Database Syst Rev; 2002; (4):CD001396. PubMed ID: 12519554
[TBL] [Abstract][Full Text] [Related]
4. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
[TBL] [Abstract][Full Text] [Related]
5. Acupuncture and acupressure for premenstrual syndrome.
Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
9. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
[TBL] [Abstract][Full Text] [Related]
10. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
Jarvis CI; Lynch AM; Morin AK
Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review.
Dimmock PW; Wyatt KM; Jones PW; O'Brien PM
Lancet; 2000 Sep; 356(9236):1131-6. PubMed ID: 11030291
[TBL] [Abstract][Full Text] [Related]
12. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
Freeman EW
CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
[TBL] [Abstract][Full Text] [Related]
13. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
Steiner M
J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein AA; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Feb; (2):CD006586. PubMed ID: 22336820
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough.
Halbreich U
CNS Spectr; 2008 Jul; 13(7):566-72. PubMed ID: 18622361
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives containing drospirenone for premenstrual syndrome.
Ma S; Song SJ
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD006586. PubMed ID: 37365881
[TBL] [Abstract][Full Text] [Related]
18. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
Steiner M; Pearlstein T; Cohen LS; Endicott J; Kornstein SG; Roberts C; Roberts DL; Yonkers K
J Womens Health (Larchmt); 2006; 15(1):57-69. PubMed ID: 16417420
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Walitt B; Urrútia G; Nishishinya MB; Cantrell SE; Häuser W
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011735. PubMed ID: 26046493
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
